Royal London Asset Management
CHRS icon

Royal London Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Royal London Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-64,256
Closed -$581K – 658
2018
Q4 		$581K Buy
+64,256
New +$581K 0.01% 649